Actively Recruiting
Study of Adults With Mastocytosis and Hypertryptasemia at University Hospital Zurich Collecting Clinical Data and Biological Samples for Research
Led by University of Zurich · Updated on 2024-06-26
400
Participants Needed
1
Research Sites
521 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting information on patients with mastocytosis and hypertryptasemia, including those without underlying mastocytosis or without a bone marrow biopsy. The study aims to summarize patients demographics, clinical progress, and treatment courses to better understand these conditions. Biological samples like serum, skin tissue, gut mucosa, and bone marrow are collected from routine diagnostics for experimental research. Participants include adults diagnosed with mastocytosis according to WHO criteria or those with repeated elevated serum tryptase without underlying mastocytosis or bone marrow biopsy. This observational study gathers data and samples without testing specific treatments or interventions. During the study, researchers review demographic data and disease progression from 2010 to 2025. Participants provide biological samples during routine care, which are used for experimental research. The study is sponsored by the University of Zurich and will continue until 2035, allowing long-term observation of patient outcomes.
CONDITIONS
Brief Title
Mastocytosis Registry (of Zurich)
Research Team
C
Claudia Lang, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here